Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pannee Leelawattanachai"'
Autor:
Nattapong Tidwong, Anan Chanruang, Suthanya Chupradit, Suzanne L. Parker, Pannee Leelawattanachai, Poramed Winichakoon, Baralee Punyawudho
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 10, Pp n/a-n/a (2024)
Abstract Fosfomycin has been used to treat carbapenem‐resistant Acinetobacter baumannii (CRAB) infections. However, there is insufficient information on dosage adjustment among critically ill patients with renal impairment. This study aims to evalu
Externí odkaz:
https://doaj.org/article/79ac0281614249c4875c3515056b13fb
Autor:
Pannee Leelawattanachai, Thitima Wattanavijitkul, Taniya Paiboonvong, Rongpong Plongla, Tanittha Chatsuwan, Sang Usayaporn, Wichit Nosoongnoen, Preecha Montakantikul
Publikováno v:
Antibiotics, Vol 9, Iss 9, p 615 (2020)
There are limited intravenous fosfomycin disodium (IVFOS) dosing regimens to treat carbapenem-resistant Enterobacterales (CRE) infections. This study aimed to use Monte Carlo simulation (MCS) for evaluation of IVFOS dosing regimens in critically ill
Externí odkaz:
https://doaj.org/article/a9db1c4a35bd4cb99e3358e3d73d3bdb
Autor:
Nattapong Tidwong, Baralee Punyawudho, Pannee Leelawattanachai, Suwida Tangtrakultham, Pitchaya Dilokpattanamongkol, Taniya Paiboonvong, Supatat Chumnumwat, Preecha Montakantikul
Publikováno v:
Pharmaceutical Sciences Asia. 48:291-299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef16ded7b64f6a56630b79534b7ada73
https://doi.org/10.29090/psa.2021.03.20.197
https://doi.org/10.29090/psa.2021.03.20.197
Autor:
Pannee Leelawattanachai1,2, Preecha Montakantikul1, Wichit Nosoongnoen1, Methee Chayakulkeeree3 methee.cha@mahidol.ac.th, Leelawattanachai, Pannee4,5 (AUTHOR), Montakantikul, Preecha4 (AUTHOR), Nosoongnoen, Wichit4 (AUTHOR), Chayakulkeeree, Methee6 (AUTHOR)
Publikováno v:
Therapeutics & Clinical Risk Management. Apr2019, Vol. 15, p589-595. 7p.
Publikováno v:
Therapeutics and Clinical Risk Management
Limited information exists regarding the optimal dose of posaconazole delayed-release tablet for the treatment of invasive mold infection. Here, we report the case of a previously healthy 44-year-old Thai man who developed coexisting invasive pulmona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e3463f7056612d5d8a95b43a9fddba
https://doi.org/10.2147/tcrm.s203625
https://doi.org/10.2147/tcrm.s203625
Autor:
Wichit Nosoongnoen, Tanittha Chatsuwan, Rongpong Plongla, Taniya Paiboonvong, Sang Usayaporn, Preecha Montakantikul, Thitima Wattanavijitkul, Pannee Leelawattanachai
Publikováno v:
Antibiotics
Volume 9
Issue 9
Antibiotics, Vol 9, Iss 615, p 615 (2020)
Volume 9
Issue 9
Antibiotics, Vol 9, Iss 615, p 615 (2020)
There are limited intravenous fosfomycin disodium (IVFOS) dosing regimens to treat carbapenem-resistant Enterobacterales (CRE) infections. This study aimed to use Monte Carlo simulation (MCS) for evaluation of IVFOS dosing regimens in critically ill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f1b1ef078be64a2fd4c5b6e9fc477d